| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tomography, X-Ray Computed | 52 | 2019 | 7551 | 2.250 |
Why?
|
| Head and Neck Neoplasms | 32 | 2020 | 3976 | 1.760 |
Why?
|
| Osteoradionecrosis | 5 | 2019 | 123 | 1.620 |
Why?
|
| Cranial Nerve Neoplasms | 7 | 2019 | 49 | 1.610 |
Why?
|
| Carcinoma, Squamous Cell | 34 | 2019 | 5437 | 1.390 |
Why?
|
| Magnetic Resonance Imaging | 49 | 2020 | 7702 | 1.350 |
Why?
|
| Temporal Bone | 6 | 2019 | 102 | 1.110 |
Why?
|
| Palate | 3 | 2011 | 22 | 0.760 |
Why?
|
| Positron-Emission Tomography | 8 | 2014 | 2173 | 0.620 |
Why?
|
| Mandibular Diseases | 2 | 2012 | 45 | 0.610 |
Why?
|
| Laryngeal Neoplasms | 7 | 2018 | 518 | 0.610 |
Why?
|
| Neurilemmoma | 2 | 2011 | 127 | 0.540 |
Why?
|
| Neoplasms, Radiation-Induced | 2 | 2011 | 388 | 0.490 |
Why?
|
| Image Enhancement | 3 | 2008 | 561 | 0.480 |
Why?
|
| Neck | 5 | 2011 | 383 | 0.480 |
Why?
|
| Neoplasm Invasiveness | 14 | 2019 | 3981 | 0.470 |
Why?
|
| Middle Aged | 78 | 2019 | 86204 | 0.470 |
Why?
|
| Contrast Media | 10 | 2020 | 1472 | 0.470 |
Why?
|
| Male | 91 | 2019 | 123000 | 0.470 |
Why?
|
| Ophthalmic Nerve | 1 | 2013 | 9 | 0.460 |
Why?
|
| Meningeal Neoplasms | 5 | 2015 | 441 | 0.450 |
Why?
|
| Oculomotor Nerve Diseases | 1 | 2013 | 27 | 0.450 |
Why?
|
| Oropharyngeal Neoplasms | 5 | 2014 | 1105 | 0.450 |
Why?
|
| Adipose Tissue | 3 | 2008 | 769 | 0.450 |
Why?
|
| Aged | 62 | 2019 | 70117 | 0.450 |
Why?
|
| Bone Diseases, Infectious | 1 | 2012 | 12 | 0.450 |
Why?
|
| Adult | 74 | 2019 | 77950 | 0.430 |
Why?
|
| Pleural Neoplasms | 1 | 2017 | 470 | 0.430 |
Why?
|
| Human papillomavirus 16 | 2 | 2013 | 256 | 0.420 |
Why?
|
| Palatal Neoplasms | 3 | 2011 | 26 | 0.410 |
Why?
|
| Humans | 126 | 2021 | 261506 | 0.410 |
Why?
|
| Soft Tissue Infections | 1 | 2012 | 102 | 0.410 |
Why?
|
| Superior Cervical Ganglion | 1 | 2011 | 18 | 0.410 |
Why?
|
| Palatal Obturators | 1 | 2011 | 17 | 0.400 |
Why?
|
| Dextroamphetamine | 1 | 2011 | 18 | 0.400 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2009 | 1648 | 0.390 |
Why?
|
| Maxilla | 1 | 2011 | 84 | 0.390 |
Why?
|
| Public Opinion | 1 | 2011 | 83 | 0.380 |
Why?
|
| Nose Neoplasms | 1 | 2013 | 229 | 0.380 |
Why?
|
| Professional-Patient Relations | 1 | 2011 | 124 | 0.370 |
Why?
|
| Hyoid Bone | 1 | 2009 | 8 | 0.370 |
Why?
|
| Carotid Arteries | 1 | 2011 | 240 | 0.360 |
Why?
|
| Otorhinolaryngologic Neoplasms | 1 | 2009 | 20 | 0.360 |
Why?
|
| Vocal Cord Paralysis | 2 | 2012 | 82 | 0.360 |
Why?
|
| Female | 81 | 2019 | 141928 | 0.360 |
Why?
|
| Orbital Neoplasms | 4 | 2014 | 224 | 0.360 |
Why?
|
| Artifacts | 3 | 2005 | 532 | 0.350 |
Why?
|
| Outsourced Services | 1 | 2009 | 2 | 0.350 |
Why?
|
| Unnecessary Procedures | 1 | 2010 | 104 | 0.350 |
Why?
|
| Teleradiology | 1 | 2009 | 9 | 0.340 |
Why?
|
| Thyroglossal Cyst | 1 | 2009 | 14 | 0.340 |
Why?
|
| Paranasal Sinus Neoplasms | 3 | 2007 | 285 | 0.330 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 2 | 2014 | 274 | 0.330 |
Why?
|
| Papillomavirus Infections | 2 | 2014 | 980 | 0.310 |
Why?
|
| Facial Nerve Diseases | 2 | 2019 | 21 | 0.310 |
Why?
|
| Pattern Recognition, Automated | 1 | 2008 | 125 | 0.310 |
Why?
|
| Academic Medical Centers | 1 | 2011 | 672 | 0.310 |
Why?
|
| Ulcer | 1 | 2008 | 78 | 0.310 |
Why?
|
| Soft Tissue Injuries | 1 | 2008 | 51 | 0.310 |
Why?
|
| Nasal Septum | 1 | 2007 | 47 | 0.300 |
Why?
|
| Carcinoma, Adenoid Cystic | 4 | 2008 | 421 | 0.290 |
Why?
|
| Maxillary Sinus Neoplasms | 2 | 2000 | 117 | 0.290 |
Why?
|
| Dimethylpolysiloxanes | 1 | 2006 | 21 | 0.290 |
Why?
|
| Thyroidectomy | 1 | 2010 | 486 | 0.290 |
Why?
|
| Silicones | 1 | 2006 | 54 | 0.290 |
Why?
|
| Skull Neoplasms | 2 | 2000 | 67 | 0.280 |
Why?
|
| Physician's Role | 1 | 2009 | 238 | 0.280 |
Why?
|
| Neoplasm Recurrence, Local | 17 | 2018 | 10035 | 0.280 |
Why?
|
| Abscess | 1 | 2007 | 177 | 0.280 |
Why?
|
| Lacrimal Apparatus Diseases | 1 | 2007 | 137 | 0.280 |
Why?
|
| Polytetrafluoroethylene | 1 | 2006 | 113 | 0.270 |
Why?
|
| Orbit | 5 | 2003 | 205 | 0.270 |
Why?
|
| Trigeminal Nerve Diseases | 2 | 2009 | 15 | 0.270 |
Why?
|
| Head | 2 | 2008 | 249 | 0.270 |
Why?
|
| Radiology | 1 | 2011 | 434 | 0.270 |
Why?
|
| Radiotherapy | 3 | 2009 | 1824 | 0.260 |
Why?
|
| Postoperative Complications | 4 | 2007 | 5542 | 0.260 |
Why?
|
| Skull Base Neoplasms | 2 | 1999 | 314 | 0.260 |
Why?
|
| Laryngectomy | 4 | 2016 | 242 | 0.260 |
Why?
|
| Cranial Nerves | 2 | 2002 | 20 | 0.250 |
Why?
|
| Sensitivity and Specificity | 8 | 2019 | 4971 | 0.250 |
Why?
|
| Retrospective Studies | 24 | 2019 | 37905 | 0.250 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2008 | 592 | 0.250 |
Why?
|
| Orbit Evisceration | 2 | 2014 | 46 | 0.240 |
Why?
|
| Thyroid Neoplasms | 3 | 2010 | 1866 | 0.240 |
Why?
|
| Prosthesis Implantation | 1 | 2006 | 263 | 0.240 |
Why?
|
| Quality of Health Care | 1 | 2009 | 621 | 0.240 |
Why?
|
| Aged, 80 and over | 20 | 2018 | 29902 | 0.240 |
Why?
|
| Diagnosis, Differential | 11 | 2015 | 4744 | 0.240 |
Why?
|
| Audiovisual Aids | 1 | 2004 | 42 | 0.230 |
Why?
|
| Radiation Injuries | 2 | 2009 | 1411 | 0.230 |
Why?
|
| Surgical Flaps | 3 | 2014 | 927 | 0.230 |
Why?
|
| Diagnostic Imaging | 2 | 2010 | 1162 | 0.230 |
Why?
|
| Brain Diseases | 2 | 2005 | 403 | 0.230 |
Why?
|
| Ear Neoplasms | 2 | 2017 | 59 | 0.230 |
Why?
|
| Lisdexamfetamine Dimesylate | 2 | 2014 | 11 | 0.220 |
Why?
|
| Meningioma | 2 | 2015 | 289 | 0.220 |
Why?
|
| Immunocompromised Host | 1 | 2007 | 698 | 0.220 |
Why?
|
| Peripheral Nervous System Neoplasms | 2 | 2000 | 72 | 0.220 |
Why?
|
| Neck Dissection | 3 | 2012 | 290 | 0.220 |
Why?
|
| Sacrum | 2 | 1994 | 132 | 0.220 |
Why?
|
| Facial Nerve | 2 | 1999 | 64 | 0.210 |
Why?
|
| Leprosy | 1 | 2021 | 33 | 0.200 |
Why?
|
| Ethmoid Sinus | 1 | 2001 | 27 | 0.200 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 15 | 2018 | 15862 | 0.200 |
Why?
|
| Spinal Cord Neoplasms | 3 | 2004 | 142 | 0.200 |
Why?
|
| Mucormycosis | 2 | 2000 | 108 | 0.200 |
Why?
|
| Lymphoma, Non-Hodgkin | 2 | 2010 | 1039 | 0.190 |
Why?
|
| Sarcoma | 1 | 2011 | 1725 | 0.190 |
Why?
|
| Pterygoid Muscles | 1 | 2000 | 3 | 0.190 |
Why?
|
| Leukemic Infiltration | 1 | 2001 | 72 | 0.190 |
Why?
|
| Ethmoid Bone | 1 | 2000 | 14 | 0.190 |
Why?
|
| Nasal Bone | 1 | 2000 | 19 | 0.190 |
Why?
|
| Alcohol Drinking | 2 | 2014 | 551 | 0.190 |
Why?
|
| Pharyngeal Neoplasms | 2 | 2012 | 133 | 0.190 |
Why?
|
| Masticatory Muscles | 1 | 2000 | 6 | 0.190 |
Why?
|
| Cancer Care Facilities | 2 | 2016 | 884 | 0.180 |
Why?
|
| Ear, External | 1 | 2000 | 42 | 0.180 |
Why?
|
| Ferrosoferric Oxide | 1 | 2020 | 40 | 0.180 |
Why?
|
| Skull Base | 2 | 2000 | 199 | 0.180 |
Why?
|
| Neoplasms, Nerve Tissue | 1 | 1999 | 5 | 0.180 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2002 | 361 | 0.180 |
Why?
|
| Ferric Compounds | 1 | 2020 | 73 | 0.180 |
Why?
|
| Vocal Cords | 2 | 2018 | 90 | 0.170 |
Why?
|
| Neck Muscles | 1 | 1999 | 38 | 0.170 |
Why?
|
| Oral Surgical Procedures | 2 | 2011 | 32 | 0.170 |
Why?
|
| Burns | 1 | 2000 | 117 | 0.170 |
Why?
|
| Angiolymphoid Hyperplasia with Eosinophilia | 1 | 1998 | 6 | 0.170 |
Why?
|
| Erlotinib Hydrochloride | 2 | 2018 | 388 | 0.170 |
Why?
|
| Maxillary Nerve | 1 | 1998 | 5 | 0.170 |
Why?
|
| Cerebral Angiography | 3 | 1994 | 129 | 0.170 |
Why?
|
| Multimodal Imaging | 2 | 2014 | 550 | 0.170 |
Why?
|
| Tonsillar Neoplasms | 1 | 2019 | 80 | 0.170 |
Why?
|
| Retinal Neoplasms | 1 | 2000 | 144 | 0.160 |
Why?
|
| Retinoblastoma | 1 | 2000 | 200 | 0.160 |
Why?
|
| Pain | 3 | 2012 | 1658 | 0.160 |
Why?
|
| Lymphatic Metastasis | 8 | 2015 | 4844 | 0.160 |
Why?
|
| Spinal Nerve Roots | 3 | 1999 | 65 | 0.160 |
Why?
|
| Technology, Radiologic | 1 | 1998 | 80 | 0.160 |
Why?
|
| Metal Nanoparticles | 1 | 2020 | 164 | 0.160 |
Why?
|
| Young Adult | 12 | 2017 | 21445 | 0.160 |
Why?
|
| Gadolinium | 2 | 1998 | 164 | 0.160 |
Why?
|
| Supratentorial Neoplasms | 1 | 1998 | 78 | 0.150 |
Why?
|
| Single-Blind Method | 2 | 2013 | 409 | 0.150 |
Why?
|
| Brain Neoplasms | 4 | 2014 | 4849 | 0.150 |
Why?
|
| Adolescent | 20 | 2014 | 31252 | 0.150 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2001 | 305 | 0.150 |
Why?
|
| Treatment Outcome | 16 | 2016 | 32848 | 0.150 |
Why?
|
| Osteomyelitis | 1 | 2000 | 236 | 0.150 |
Why?
|
| Mouth Neoplasms | 2 | 2013 | 713 | 0.150 |
Why?
|
| Foreign Bodies | 2 | 2002 | 145 | 0.150 |
Why?
|
| Algorithms | 1 | 2008 | 3890 | 0.150 |
Why?
|
| Subarachnoid Space | 1 | 1996 | 36 | 0.140 |
Why?
|
| Software | 1 | 2004 | 1321 | 0.140 |
Why?
|
| Dental Enamel Hypoplasia | 1 | 1996 | 1 | 0.140 |
Why?
|
| Radiography | 5 | 2008 | 1904 | 0.140 |
Why?
|
| Cisplatin | 7 | 2018 | 2432 | 0.140 |
Why?
|
| Smoking | 3 | 2015 | 2440 | 0.140 |
Why?
|
| Follow-Up Studies | 10 | 2016 | 14889 | 0.140 |
Why?
|
| Melanoma | 2 | 2013 | 5317 | 0.140 |
Why?
|
| Pleura | 1 | 2017 | 127 | 0.140 |
Why?
|
| Syndactyly | 1 | 1996 | 26 | 0.140 |
Why?
|
| Microphthalmos | 1 | 1996 | 57 | 0.130 |
Why?
|
| Laminectomy | 1 | 2015 | 52 | 0.130 |
Why?
|
| Cervical Cord | 1 | 2015 | 19 | 0.130 |
Why?
|
| Facial Neoplasms | 2 | 2009 | 84 | 0.130 |
Why?
|
| Basilar Artery | 1 | 1994 | 25 | 0.130 |
Why?
|
| Mandibular Condyle | 1 | 1994 | 6 | 0.120 |
Why?
|
| Glioma | 2 | 1998 | 1963 | 0.120 |
Why?
|
| Pharynx | 3 | 2010 | 153 | 0.120 |
Why?
|
| Bone Diseases | 2 | 2014 | 143 | 0.120 |
Why?
|
| Prognosis | 9 | 2018 | 21713 | 0.120 |
Why?
|
| Myocutaneous Flap | 1 | 2014 | 30 | 0.120 |
Why?
|
| Cerebral Veins | 1 | 1994 | 28 | 0.120 |
Why?
|
| Cerebral Infarction | 1 | 1994 | 59 | 0.120 |
Why?
|
| Sphenoid Bone | 1 | 1994 | 22 | 0.120 |
Why?
|
| Skin Neoplasms | 3 | 2017 | 4654 | 0.120 |
Why?
|
| Syringes | 1 | 1994 | 42 | 0.120 |
Why?
|
| Embolism, Air | 1 | 1994 | 33 | 0.120 |
Why?
|
| Meninges | 1 | 1994 | 47 | 0.120 |
Why?
|
| Fascia | 1 | 2014 | 68 | 0.120 |
Why?
|
| Genes, bcl-1 | 1 | 2013 | 24 | 0.120 |
Why?
|
| Radiographic Image Enhancement | 2 | 2013 | 402 | 0.120 |
Why?
|
| Wood | 1 | 1993 | 18 | 0.120 |
Why?
|
| Inflammation | 2 | 2009 | 2522 | 0.120 |
Why?
|
| Survival Analysis | 6 | 2018 | 9180 | 0.120 |
Why?
|
| Survival Rate | 12 | 2015 | 12221 | 0.120 |
Why?
|
| Biopsy | 6 | 2021 | 3443 | 0.110 |
Why?
|
| Intracranial Aneurysm | 1 | 1994 | 123 | 0.110 |
Why?
|
| Angiogenic Proteins | 1 | 2013 | 37 | 0.110 |
Why?
|
| Skin Transplantation | 1 | 2014 | 173 | 0.110 |
Why?
|
| Neck Injuries | 1 | 1993 | 32 | 0.110 |
Why?
|
| Central Nervous System | 1 | 1995 | 436 | 0.110 |
Why?
|
| Osteosarcoma | 1 | 2000 | 929 | 0.110 |
Why?
|
| Wounds, Penetrating | 1 | 1993 | 89 | 0.110 |
Why?
|
| Carotid Artery Diseases | 1 | 1994 | 196 | 0.110 |
Why?
|
| Executive Function | 1 | 2014 | 160 | 0.110 |
Why?
|
| Mandibular Osteotomy | 1 | 2012 | 33 | 0.110 |
Why?
|
| Quinazolines | 1 | 2017 | 923 | 0.110 |
Why?
|
| Hyperbaric Oxygenation | 1 | 2012 | 48 | 0.110 |
Why?
|
| Osteitis Deformans | 1 | 1992 | 34 | 0.110 |
Why?
|
| Carboxymethylcellulose Sodium | 1 | 2012 | 18 | 0.110 |
Why?
|
| Central Nervous System Stimulants | 1 | 2014 | 225 | 0.100 |
Why?
|
| Craniocerebral Trauma | 1 | 1993 | 130 | 0.100 |
Why?
|
| Aicardi Syndrome | 1 | 2012 | 16 | 0.100 |
Why?
|
| Sympathetic Fibers, Postganglionic | 1 | 2011 | 6 | 0.100 |
Why?
|
| Dental Prosthesis Retention | 1 | 2011 | 5 | 0.100 |
Why?
|
| Endodermal Sinus Tumor | 1 | 2012 | 47 | 0.100 |
Why?
|
| Laryngoplasty | 1 | 2012 | 25 | 0.100 |
Why?
|
| Sarcoidosis | 1 | 1993 | 112 | 0.100 |
Why?
|
| Lumbar Vertebrae | 1 | 1993 | 245 | 0.100 |
Why?
|
| Mandible | 1 | 2012 | 188 | 0.100 |
Why?
|
| Radiopharmaceuticals | 3 | 2011 | 1301 | 0.100 |
Why?
|
| Positron Emission Tomography Computed Tomography | 1 | 2017 | 833 | 0.100 |
Why?
|
| Fluorodeoxyglucose F18 | 3 | 2011 | 1226 | 0.100 |
Why?
|
| Paclitaxel | 8 | 2009 | 1996 | 0.090 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 1992 | 144 | 0.090 |
Why?
|
| Lymph Node Excision | 2 | 2009 | 1959 | 0.090 |
Why?
|
| Neoplasm Staging | 7 | 2016 | 13658 | 0.090 |
Why?
|
| Disease Progression | 3 | 2019 | 6682 | 0.090 |
Why?
|
| Tongue | 1 | 2009 | 77 | 0.090 |
Why?
|
| Mass Screening | 1 | 1998 | 1509 | 0.090 |
Why?
|
| Health Care Reform | 1 | 2010 | 68 | 0.090 |
Why?
|
| Injections | 3 | 2012 | 285 | 0.090 |
Why?
|
| Radiotherapy, Conformal | 1 | 2014 | 902 | 0.080 |
Why?
|
| Sinus Thrombosis, Intracranial | 1 | 1989 | 42 | 0.080 |
Why?
|
| Chemoradiotherapy | 1 | 2018 | 1946 | 0.080 |
Why?
|
| Granulomatosis with Polyangiitis | 1 | 1989 | 46 | 0.080 |
Why?
|
| Anti-Infective Agents | 1 | 2012 | 446 | 0.080 |
Why?
|
| Spin Labels | 1 | 2008 | 76 | 0.080 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2015 | 5178 | 0.080 |
Why?
|
| Ear Canal | 1 | 2008 | 31 | 0.080 |
Why?
|
| Incidence | 3 | 2014 | 5673 | 0.080 |
Why?
|
| Incidental Findings | 1 | 2010 | 272 | 0.080 |
Why?
|
| Nose Diseases | 1 | 2007 | 10 | 0.080 |
Why?
|
| Gadolinium DTPA | 3 | 2000 | 172 | 0.080 |
Why?
|
| Histiocytosis, Sinus | 1 | 2008 | 86 | 0.080 |
Why?
|
| Hernia | 1 | 2007 | 46 | 0.080 |
Why?
|
| Ifosfamide | 6 | 2009 | 344 | 0.080 |
Why?
|
| Carcinoma, Mucoepidermoid | 1 | 2009 | 137 | 0.080 |
Why?
|
| Precancerous Conditions | 1 | 2014 | 1058 | 0.080 |
Why?
|
| Nasolacrimal Duct | 1 | 2007 | 53 | 0.080 |
Why?
|
| Bone Neoplasms | 2 | 2017 | 2576 | 0.080 |
Why?
|
| Lymph Nodes | 3 | 2013 | 2967 | 0.070 |
Why?
|
| Quality Indicators, Health Care | 1 | 2010 | 348 | 0.070 |
Why?
|
| Lymphoma, B-Cell, Marginal Zone | 1 | 2010 | 301 | 0.070 |
Why?
|
| Child | 12 | 2014 | 29154 | 0.070 |
Why?
|
| Salvage Therapy | 1 | 2015 | 2054 | 0.070 |
Why?
|
| Leukemia | 1 | 1995 | 1635 | 0.070 |
Why?
|
| Thiazoles | 1 | 2010 | 726 | 0.070 |
Why?
|
| Guideline Adherence | 1 | 2010 | 636 | 0.070 |
Why?
|
| Risk Factors | 5 | 2015 | 17523 | 0.070 |
Why?
|
| Reproducibility of Results | 3 | 2014 | 6009 | 0.070 |
Why?
|
| Sinusitis | 2 | 1998 | 131 | 0.070 |
Why?
|
| Carcinoma, Papillary | 1 | 2009 | 584 | 0.070 |
Why?
|
| Tomography Scanners, X-Ray Computed | 1 | 2005 | 88 | 0.070 |
Why?
|
| Aging | 1 | 1994 | 1582 | 0.060 |
Why?
|
| Skin | 2 | 2001 | 1259 | 0.060 |
Why?
|
| Health Care Costs | 1 | 2010 | 674 | 0.060 |
Why?
|
| Brain | 3 | 1999 | 4113 | 0.060 |
Why?
|
| Pentetic Acid | 2 | 1995 | 48 | 0.060 |
Why?
|
| Piperidines | 1 | 2009 | 1035 | 0.060 |
Why?
|
| Sphenoid Sinusitis | 2 | 2000 | 5 | 0.060 |
Why?
|
| Neoadjuvant Therapy | 1 | 2016 | 4975 | 0.060 |
Why?
|
| Carboplatin | 4 | 2009 | 823 | 0.060 |
Why?
|
| Philadelphia | 1 | 2002 | 38 | 0.060 |
Why?
|
| Glioblastoma | 1 | 2014 | 1797 | 0.060 |
Why?
|
| Radiotherapy, Adjuvant | 4 | 2016 | 2231 | 0.060 |
Why?
|
| Neoplasm Metastasis | 5 | 2018 | 5112 | 0.050 |
Why?
|
| Organometallic Compounds | 2 | 1995 | 191 | 0.050 |
Why?
|
| Chemotherapy, Adjuvant | 5 | 2016 | 3890 | 0.050 |
Why?
|
| Diplopia | 1 | 2002 | 66 | 0.050 |
Why?
|
| Education | 1 | 2002 | 112 | 0.050 |
Why?
|
| Pyridines | 1 | 2009 | 1244 | 0.050 |
Why?
|
| Antineoplastic Agents | 3 | 2017 | 14289 | 0.050 |
Why?
|
| Decision Making | 1 | 2010 | 1287 | 0.050 |
Why?
|
| Mycobacterium leprae | 1 | 2021 | 16 | 0.050 |
Why?
|
| Reoperation | 1 | 2006 | 1382 | 0.050 |
Why?
|
| Ependymoma | 1 | 2004 | 242 | 0.050 |
Why?
|
| Child, Preschool | 6 | 2014 | 16273 | 0.050 |
Why?
|
| Cerebrospinal Fluid | 1 | 2002 | 120 | 0.050 |
Why?
|
| Radiotherapy Dosage | 1 | 2009 | 3842 | 0.050 |
Why?
|
| Disease-Free Survival | 5 | 2016 | 10001 | 0.050 |
Why?
|
| Pilot Projects | 1 | 2008 | 2803 | 0.050 |
Why?
|
| Radiology, Interventional | 1 | 2002 | 138 | 0.050 |
Why?
|
| Prolactinoma | 1 | 2000 | 11 | 0.050 |
Why?
|
| Tolosa-Hunt Syndrome | 1 | 2000 | 7 | 0.050 |
Why?
|
| Patient Care Team | 1 | 2006 | 795 | 0.050 |
Why?
|
| Visual Acuity | 2 | 2002 | 873 | 0.050 |
Why?
|
| Dental Restoration, Permanent | 1 | 2000 | 5 | 0.050 |
Why?
|
| Maxillary Sinus | 1 | 2000 | 19 | 0.050 |
Why?
|
| Aminoquinolines | 1 | 2000 | 46 | 0.050 |
Why?
|
| Cicatrix | 1 | 2002 | 208 | 0.050 |
Why?
|
| Ultrasonography | 2 | 2021 | 1863 | 0.050 |
Why?
|
| Dopamine Agonists | 1 | 2000 | 85 | 0.050 |
Why?
|
| Severity of Illness Index | 1 | 2011 | 4320 | 0.050 |
Why?
|
| Sphenoid Sinus | 1 | 2000 | 21 | 0.050 |
Why?
|
| Face | 2 | 2000 | 273 | 0.050 |
Why?
|
| Observer Variation | 1 | 2002 | 671 | 0.050 |
Why?
|
| Carcinoma | 2 | 2003 | 2578 | 0.050 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2013 | 2979 | 0.040 |
Why?
|
| Radiculopathy | 1 | 1999 | 9 | 0.040 |
Why?
|
| Peripheral Nerves | 1 | 2000 | 159 | 0.040 |
Why?
|
| Radiotherapy Planning, Computer-Assisted | 1 | 2009 | 2370 | 0.040 |
Why?
|
| Adenocarcinoma | 1 | 2017 | 7789 | 0.040 |
Why?
|
| Muscular Diseases | 1 | 2000 | 161 | 0.040 |
Why?
|
| Neurologic Examination | 2 | 1997 | 245 | 0.040 |
Why?
|
| Fellowships and Scholarships | 1 | 2002 | 390 | 0.040 |
Why?
|
| Parotid Gland | 1 | 1998 | 112 | 0.040 |
Why?
|
| Pituitary Neoplasms | 1 | 2000 | 203 | 0.040 |
Why?
|
| Dura Mater | 2 | 1997 | 73 | 0.040 |
Why?
|
| Double-Blind Method | 2 | 2014 | 2588 | 0.040 |
Why?
|
| Thalidomide | 1 | 2001 | 569 | 0.040 |
Why?
|
| Pyrimidines | 1 | 2010 | 3518 | 0.040 |
Why?
|
| Recurrence | 1 | 2006 | 4758 | 0.040 |
Why?
|
| Intracranial Pressure | 1 | 1999 | 180 | 0.040 |
Why?
|
| Trigeminal Nerve | 2 | 1996 | 15 | 0.040 |
Why?
|
| Respiratory Hypersensitivity | 1 | 1998 | 51 | 0.040 |
Why?
|
| Prospective Studies | 4 | 2020 | 12873 | 0.040 |
Why?
|
| Angiography | 2 | 1996 | 360 | 0.040 |
Why?
|
| Ear, Middle | 1 | 2017 | 48 | 0.040 |
Why?
|
| Chronic Disease | 2 | 2000 | 1819 | 0.040 |
Why?
|
| Neurocytoma | 1 | 1997 | 17 | 0.040 |
Why?
|
| Nasopharyngeal Neoplasms | 1 | 1999 | 323 | 0.040 |
Why?
|
| Combined Modality Therapy | 5 | 2010 | 8865 | 0.040 |
Why?
|
| Facial Neuralgia | 1 | 1996 | 5 | 0.040 |
Why?
|
| Cerebral Ventricle Neoplasms | 1 | 1997 | 81 | 0.040 |
Why?
|
| Meningitis, Fungal | 1 | 1996 | 7 | 0.030 |
Why?
|
| ROC Curve | 2 | 2010 | 1183 | 0.030 |
Why?
|
| Brain Stem | 1 | 1997 | 175 | 0.030 |
Why?
|
| Multivariate Analysis | 2 | 2016 | 4298 | 0.030 |
Why?
|
| Administration, Oral | 2 | 2015 | 1544 | 0.030 |
Why?
|
| Risk Assessment | 3 | 2015 | 6869 | 0.030 |
Why?
|
| Pain, Intractable | 1 | 1997 | 171 | 0.030 |
Why?
|
| Gyrus Cinguli | 1 | 1997 | 140 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2016 | 6207 | 0.030 |
Why?
|
| Facial Paralysis | 1 | 1996 | 60 | 0.030 |
Why?
|
| ErbB Receptors | 2 | 2017 | 2295 | 0.030 |
Why?
|
| Carotid Artery, External | 1 | 1995 | 14 | 0.030 |
Why?
|
| Lymphoma, B-Cell | 1 | 2002 | 895 | 0.030 |
Why?
|
| Spinal Diseases | 2 | 1993 | 125 | 0.030 |
Why?
|
| Vocal Cord Dysfunction | 1 | 2015 | 15 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2010 | 4757 | 0.030 |
Why?
|
| Genes, Dominant | 1 | 1996 | 331 | 0.030 |
Why?
|
| Cavernous Sinus | 1 | 1995 | 33 | 0.030 |
Why?
|
| Platinum | 1 | 2015 | 138 | 0.030 |
Why?
|
| Foramen Magnum | 1 | 1994 | 7 | 0.030 |
Why?
|
| Matched-Pair Analysis | 1 | 2014 | 103 | 0.030 |
Why?
|
| Glass | 1 | 1994 | 30 | 0.030 |
Why?
|
| Nerve Block | 1 | 1996 | 176 | 0.030 |
Why?
|
| Astrocytoma | 1 | 1997 | 321 | 0.030 |
Why?
|
| Corpus Callosum | 1 | 1995 | 138 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2020 | 2292 | 0.030 |
Why?
|
| Mycoses | 1 | 1998 | 386 | 0.030 |
Why?
|
| Cohort Studies | 2 | 2018 | 9244 | 0.030 |
Why?
|
| Causality | 1 | 2014 | 178 | 0.030 |
Why?
|
| Opportunistic Infections | 1 | 1996 | 223 | 0.030 |
Why?
|
| Arteriovenous Fistula | 1 | 1995 | 92 | 0.030 |
Why?
|
| Remission Induction | 2 | 2012 | 3569 | 0.030 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2001 | 1248 | 0.030 |
Why?
|
| Cranial Sinuses | 1 | 1994 | 24 | 0.030 |
Why?
|
| Dominance, Cerebral | 1 | 1994 | 81 | 0.030 |
Why?
|
| Lipomatosis, Multiple Symmetrical | 1 | 1993 | 2 | 0.030 |
Why?
|
| Jugular Veins | 1 | 1994 | 107 | 0.030 |
Why?
|
| Spinal Cord | 2 | 1999 | 690 | 0.030 |
Why?
|
| Texas | 2 | 2016 | 6311 | 0.030 |
Why?
|
| Plastics | 1 | 1994 | 93 | 0.030 |
Why?
|
| Klippel-Feil Syndrome | 1 | 1993 | 11 | 0.030 |
Why?
|
| Muscle, Skeletal | 1 | 2001 | 1270 | 0.030 |
Why?
|
| Chromosome Disorders | 1 | 1996 | 417 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2014 | 495 | 0.030 |
Why?
|
| Central Nervous System Diseases | 1 | 1994 | 129 | 0.030 |
Why?
|
| Awareness | 1 | 2014 | 126 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 1998 | 4938 | 0.030 |
Why?
|
| Parotid Neoplasms | 1 | 2014 | 148 | 0.030 |
Why?
|
| Everolimus | 1 | 2015 | 415 | 0.030 |
Why?
|
| Age Distribution | 1 | 2014 | 698 | 0.030 |
Why?
|
| Genetic Vectors | 1 | 1998 | 1694 | 0.030 |
Why?
|
| Adenoviridae | 1 | 1998 | 1459 | 0.030 |
Why?
|
| Syndrome | 1 | 1996 | 1351 | 0.030 |
Why?
|
| Arteries | 1 | 1994 | 274 | 0.030 |
Why?
|
| Pregnancy Complications, Neoplastic | 1 | 2014 | 222 | 0.030 |
Why?
|
| Histiocytosis, Langerhans-Cell | 1 | 1995 | 261 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2016 | 2307 | 0.030 |
Why?
|
| Gastroesophageal Reflux | 1 | 2015 | 334 | 0.030 |
Why?
|
| Cervical Vertebrae | 1 | 1993 | 205 | 0.030 |
Why?
|
| Voice Quality | 1 | 2012 | 33 | 0.030 |
Why?
|
| Statistics as Topic | 1 | 2013 | 445 | 0.030 |
Why?
|
| Reference Values | 1 | 1994 | 1099 | 0.030 |
Why?
|
| Data Collection | 1 | 1994 | 620 | 0.030 |
Why?
|
| In Vitro Techniques | 1 | 1994 | 1618 | 0.030 |
Why?
|
| Cerebellum | 1 | 1995 | 449 | 0.020 |
Why?
|
| United States | 3 | 2015 | 15433 | 0.020 |
Why?
|
| Isotretinoin | 2 | 2002 | 158 | 0.020 |
Why?
|
| Deglutition Disorders | 1 | 2015 | 447 | 0.020 |
Why?
|
| Self Report | 1 | 2014 | 756 | 0.020 |
Why?
|
| Glottis | 1 | 2010 | 67 | 0.020 |
Why?
|
| Cheek | 1 | 2009 | 70 | 0.020 |
Why?
|
| Facial Bones | 2 | 1999 | 40 | 0.020 |
Why?
|
| Otologic Surgical Procedures | 1 | 2008 | 33 | 0.020 |
Why?
|
| Chromosome Aberrations | 1 | 1996 | 1960 | 0.020 |
Why?
|
| Necrosis | 1 | 2010 | 580 | 0.020 |
Why?
|
| Cetuximab | 1 | 2009 | 472 | 0.020 |
Why?
|
| Comorbidity | 1 | 2014 | 2352 | 0.020 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2011 | 690 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2016 | 4988 | 0.020 |
Why?
|
| Paranasal Sinuses | 2 | 1999 | 61 | 0.020 |
Why?
|
| Interferon-alpha | 2 | 2002 | 889 | 0.020 |
Why?
|
| Dasatinib | 1 | 2010 | 862 | 0.020 |
Why?
|
| Patient Care Planning | 2 | 1999 | 297 | 0.020 |
Why?
|
| Taxoids | 2 | 2002 | 967 | 0.020 |
Why?
|
| Papillomaviridae | 1 | 2009 | 624 | 0.020 |
Why?
|
| Neoplasm, Residual | 1 | 2012 | 1656 | 0.020 |
Why?
|
| Palliative Care | 1 | 1997 | 2037 | 0.020 |
Why?
|
| Maximum Tolerated Dose | 1 | 2009 | 1290 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 1998 | 3552 | 0.020 |
Why?
|
| Prevalence | 1 | 2013 | 3260 | 0.020 |
Why?
|
| Genome, Human | 1 | 2013 | 1869 | 0.020 |
Why?
|
| Carcinoma, Renal Cell | 1 | 1996 | 2326 | 0.010 |
Why?
|
| Eye Enucleation | 1 | 2003 | 91 | 0.010 |
Why?
|
| Infusions, Intra-Arterial | 1 | 2003 | 171 | 0.010 |
Why?
|
| Antineoplastic Agents, Phytogenic | 2 | 1998 | 852 | 0.010 |
Why?
|
| Mesna | 1 | 2002 | 65 | 0.010 |
Why?
|
| Kidney Neoplasms | 1 | 1996 | 3022 | 0.010 |
Why?
|
| Biomarkers, Tumor | 1 | 2001 | 10331 | 0.010 |
Why?
|
| Injections, Subcutaneous | 1 | 2002 | 334 | 0.010 |
Why?
|
| Cytokines | 1 | 2010 | 2809 | 0.010 |
Why?
|
| Infant | 2 | 1994 | 13310 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 2002 | 573 | 0.010 |
Why?
|
| Vitamin E | 1 | 2001 | 136 | 0.010 |
Why?
|
| Forehead | 1 | 2000 | 27 | 0.010 |
Why?
|
| Pregnancy | 1 | 2014 | 7573 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 2003 | 1382 | 0.010 |
Why?
|
| Time Factors | 1 | 2015 | 12926 | 0.010 |
Why?
|
| Prolactin | 1 | 2000 | 155 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2010 | 2403 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2009 | 4892 | 0.010 |
Why?
|
| Oropharynx | 1 | 1999 | 74 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2013 | 5539 | 0.010 |
Why?
|
| Fever | 1 | 2002 | 497 | 0.010 |
Why?
|
| Ethmoid Sinusitis | 1 | 1998 | 6 | 0.010 |
Why?
|
| Radiotherapy, Intensity-Modulated | 1 | 2010 | 2104 | 0.010 |
Why?
|
| Frontal Sinusitis | 1 | 1998 | 5 | 0.010 |
Why?
|
| Maxillary Sinusitis | 1 | 1998 | 8 | 0.010 |
Why?
|
| Nasal Cavity | 1 | 1999 | 149 | 0.010 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2009 | 3251 | 0.010 |
Why?
|
| Injections, Intralesional | 1 | 1998 | 164 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 1998 | 406 | 0.010 |
Why?
|
| Drug Synergism | 1 | 2001 | 1313 | 0.010 |
Why?
|
| Chondrosarcoma | 1 | 2000 | 216 | 0.010 |
Why?
|
| Bone Remodeling | 1 | 1998 | 104 | 0.010 |
Why?
|
| Septum Pellucidum | 1 | 1997 | 11 | 0.010 |
Why?
|
| Neutropenia | 1 | 2002 | 968 | 0.010 |
Why?
|
| Neoplasm Seeding | 1 | 1997 | 66 | 0.010 |
Why?
|
| Phenytoin | 1 | 1997 | 71 | 0.010 |
Why?
|
| Endoscopy | 1 | 2000 | 479 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2009 | 4367 | 0.010 |
Why?
|
| Ischemia | 1 | 1999 | 391 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2002 | 2084 | 0.010 |
Why?
|
| Pons | 1 | 1996 | 51 | 0.010 |
Why?
|
| Fatigue | 1 | 2002 | 1239 | 0.010 |
Why?
|
| Temporal Lobe | 1 | 1997 | 192 | 0.010 |
Why?
|
| Gene Transfer Techniques | 1 | 1998 | 716 | 0.010 |
Why?
|
| Etoposide | 1 | 1997 | 870 | 0.010 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 1995 | 100 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2002 | 5395 | 0.010 |
Why?
|
| Veins | 1 | 1995 | 157 | 0.010 |
Why?
|
| Neuroendocrine Tumors | 1 | 2000 | 634 | 0.010 |
Why?
|
| Spinal Osteophytosis | 1 | 1993 | 6 | 0.010 |
Why?
|
| Spinal Canal | 1 | 1993 | 14 | 0.010 |
Why?
|
| Myelography | 1 | 1993 | 16 | 0.010 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 1997 | 588 | 0.010 |
Why?
|
| Anticonvulsants | 1 | 1997 | 431 | 0.010 |
Why?
|
| Blood Flow Velocity | 1 | 1995 | 475 | 0.010 |
Why?
|
| Intervertebral Disc | 1 | 1993 | 21 | 0.010 |
Why?
|
| Sex Factors | 1 | 1998 | 2139 | 0.010 |
Why?
|
| Neoplasms, Second Primary | 1 | 2001 | 1350 | 0.010 |
Why?
|
| Arnold-Chiari Malformation | 1 | 1993 | 43 | 0.010 |
Why?
|
| DNA, Neoplasm | 1 | 1998 | 1910 | 0.010 |
Why?
|
| Spinal Cord Diseases | 1 | 1993 | 90 | 0.010 |
Why?
|
| Cholangiocarcinoma | 1 | 1997 | 493 | 0.010 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 1997 | 607 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 1998 | 3203 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 1997 | 3472 | 0.010 |
Why?
|
| Scoliosis | 1 | 1993 | 139 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 2014 | 11538 | 0.010 |
Why?
|
| Neoplasms | 1 | 1997 | 15193 | 0.010 |
Why?
|
| Seizures | 1 | 1997 | 989 | 0.010 |
Why?
|
| Cyclophosphamide | 1 | 1997 | 3001 | 0.010 |
Why?
|
| Age Factors | 1 | 1998 | 5377 | 0.010 |
Why?
|
| Apoptosis | 1 | 2002 | 7591 | 0.000 |
Why?
|
| Immunohistochemistry | 1 | 1998 | 7548 | 0.000 |
Why?
|
| Breast Neoplasms | 1 | 1999 | 15694 | 0.000 |
Why?
|